These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 33807389)
1. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Zarrilli G; Galuppini F; Angerilli V; Munari G; Sabbadin M; Lazzarin V; Nicolè L; Biancotti R; Fassan M Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807389 [TBL] [Abstract][Full Text] [Related]
2. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023 [TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma. Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377 [TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis. Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686 [TBL] [Abstract][Full Text] [Related]
5. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer. Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers. Bobryshev YV; Orekhov AN; Chistiakov DA Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500 [TBL] [Abstract][Full Text] [Related]
8. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391 [TBL] [Abstract][Full Text] [Related]
9. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus. Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in esophageal squamous cell carcinoma: Application in prognosis, diagnosis, and drug delivery. Mohammadi E; Aliarab A; Babaei G; Habibi NK; Jafari SM; Mir SM; Memar MY Pathol Res Pract; 2022 Dec; 240():154196. PubMed ID: 36356334 [TBL] [Abstract][Full Text] [Related]
13. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence. Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases. Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271 [TBL] [Abstract][Full Text] [Related]
16. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412 [TBL] [Abstract][Full Text] [Related]
17. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805 [TBL] [Abstract][Full Text] [Related]
18. Identifying potential metastasis-related long non-coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma. Yang F; Wen S; Zhang Y; Xu Y; Lv H; Zhu Y; Wang M; Su P; Huang C; Tian Z J Cell Biochem; 2019 Aug; 120(8):13202-13215. PubMed ID: 30891809 [TBL] [Abstract][Full Text] [Related]
19. Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671 [No Abstract] [Full Text] [Related]